Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotype expression in familial combined hyperlipidemia

K V Porkka1, I Nuotio, P Pajukanta

  • 1Department of Medicine, HUCH, University of Helsinki, Finland. kimmo.porkka@muikku.huch.fi

Atherosclerosis
|September 23, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of transcatheter atrial septal defect closure in a nationwide cohort.

Annals of medicine·2023
Same author

Young adults' human papillomavirus-related knowledge: source of medical information matters.

Public health·2020
Same author

Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.

European journal of neurology·2017
Same author

Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

European journal of neurology·2015
Same author

Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score.

Genes, brain, and behavior·2012

Familial combined hyperlipidaemia (FCHL) diagnosis depends heavily on chosen criteria, impacting affected percentages. Re-evaluating diagnostic standards for FCHL is crucial for accurate identification.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiovascular Disease

Background:

  • Familial combined hyperlipidaemia (FCHL) is a common hereditary disorder linked to early coronary death.
  • Affected individuals exhibit elevated serum total cholesterol, triglycerides, or both.
  • The underlying genetic and metabolic defects of FCHL remain largely unknown.

Purpose of the Study:

  • To investigate the influence of diagnostic criteria on phenotype definition in FCHL.
  • To identify factors affecting phenotype expression in Finnish FCHL families.
  • To explore potential reliable metabolic markers for FCHL diagnosis.

Main Methods:

  • Analysis of 16 large Finnish families (n=255) with FCHL.
  • Assessment of diagnostic criteria using different percentile cut-points (90th vs. 95th).

Related Experiment Videos

  • Lipoprotein particle analysis (VLDL, IDL, LDL, HDL) via ultracentrifugation.
  • Linkage analysis to identify genetic associations.

    • Main Results:

    • The choice of percentile cut-points significantly altered FCHL diagnosis rates (45% with 90th vs. 22% with 95th).
    • No single ultracentrifugation variable reliably distinguished affected from non-affected family members.
    • Linkage analysis did not identify a single discriminating variable.

    Conclusions:

    • Current diagnostic criteria for FCHL require re-evaluation due to their significant impact on phenotype definition.
    • There is a need for a single, reliable metabolic marker for precise FCHL diagnosis.
    • Understanding FCHL genetics and metabolism necessitates refined diagnostic approaches.